The physiologic perturbations associated with renal disease can have a pronounced effect on the kinetics of elimination of drugs and their metabolites from the body. Drugs are ordinarily cleared from the body by a number of routes, each of which can be characterized by a clearance value.
How are drugs cleared in the kidneys?
Most drugs (or metabolites) are excreted by the kidneys. Three process can occur in renal excretion: glomerular filtration, tubular secretion and passive reabsorption. Some drugs are eliminated by the liver in the bile and excreted in feces.
What is clearance pharmacokinetics?
In pharmacology, clearance is a pharmacokinetic measurement of the volume of plasma from which a substance is completely removed per unit time. Usually, clearance is measured in L/h or mL/min.
What is kidney clearance?
Renal clearance (ClR) is a measure of kidney transport in units of volume of plasma per unit time. The volume of plasma measured is that volume for which a given substance (e.g., urea or drugs) is completely removed per minute.
What is creatinine clearance?
Definition. The creatinine clearance test helps provide information about how well the kidneys are working. The test compares the creatinine level in urine with the creatinine level in blood.
Is GFR same as creatinine clearance?
Creatinine clearance ( CrCl ) is an estimate of Glomerular Filtration Rate ( GFR ); however, CrCl is slightly higher than true GFR because creatinine is secreted by the proximal tubule (in addition to being filtered by the glomerulus).
How is renal clearance of a drug calculated?
Another equation can calculate clearance. Clearance is equal to the rate at which a drug is removed from plasma(mg/min) divided by the concentration of that drug in the plasma (mg/mL).
What is pharmacokinetics of a drug?
Pharmacokinetics is currently defined as the study of the time course of drug absorption, distribution, metabo- lism, and excretion. Clinical pharmacokinetics is the application of pharmacokinetic principles to the safe and effective therapeutic management of drugs in an individual patient.
What factors affect clearance?
Factors affecting Clearance:
- Inherent ability of the clearing organ to eliminate the drug. Any disease process might interfere.
- Blood flow to the organ- which sometimes is dependent on cardiac output. In severe cases functions of excretory organs might be affected.
What is the significance of renal clearance?
The amount of blood the kidneys can make creatinine-free each minute is called the creatinine clearance. Creatinine clearance in a healthy young person is about 95 milliliters (mL) per minute for women and 120 mL per minute for men.
What increases renal clearance?
Increased GFR will increase clearance, while decreased GFR will decrease clearance. Increased tubular secretion will increase clearance, while decreased tubular secretion will decrease clearance. This variable is sometimes altered through changes in the expression of ATPase pumps involved in active transport.
How does renal disease affect the clearance of drugs?
The physiologic perturbations associated with renal disease can have a pronounced effect on the kinetics of elimination of drugs and their metabolites from the body. Drugs are ordinarily cleared from the body by a number of routes, each of which can be characterized by a clearance value.
How is renal function assessed in pharmacokinetics?
Renal function is usually assessed based on glomerular fil tration rate (GFR). Although renal excretion of a drug may involve tubular secretion as well as glomerular filtration, it is considered sufficient to use GFR as a global measure of renal function in the pharmacokinetic study, also for secreted drugs.
Can kidney disease cause pharmacokinetics to change?
Furthermore, kidney disease can cause wide-ranging changes in pharmacokinetics through derangement of not only kidney drug CL but also, nonrenal CL, Vd, and bioavailability. These considerations apply to both the parent drug and any active or toxic metabolites.
How are drug dosing regimens determined for patients with kidney disease?
During drug development, dosing regimens are initially determined in patients with normal or mildly impaired kidney function. The drugs are then trialed in a smaller number of patients with more severe kidney disease before registration.
